Glancy Prongay & Murray LLP Commences Investigation On

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
43
Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Evoqua Water Technologies Corp. Investors (AQUA)

LOS ANGELES, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) announces that it is investigating potential claims on behalf of investors of Evoqua Water Technologies Corp. (NYSE: AQUA ) (“Evoqua” or “the Company”) and whether the Company’s officers and directors complied with their legal obligations to the Company and its shareholders.

On October 30, 2018, Evoqua announced poor preliminary financial results for the fourth quarter and fiscal year ended September 30, 2018. Evoqua disclosed that the underperformances were “primarily due to acquisition system integration issues, supply chain disruptions influenced by tariffs and an extended delay on a large aquatics project.”

GPM’s investigation focuses on whether the Company and its directors breached any fiduciary duties owed to shareholders.

If you own Evoqua shares, if you have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com , or visit our website at www.glancylaw.com . If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact: Glancy, Prongay & Murray LLP, Los Angeles Lesley Portnoy, 310-201-9150 or 888-773-9224 shareholders@glancylaw.com www.glancylaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

MIT45 Takes a Stand Against Synthetic Kratom Practices

Updated Category News Views 248

MIT45's Firm Stance on Kratom Safety MIT45, a leading name in the kratom market, stands firmly against the irresponsible and hazardous practice of producing synthetic 7-hydroxymitragynine (7-OH). This commitment to consumer protection is especially important as products claiming to contain kratom often do not meet safety standards and could threaten public health. By...

Continue Reading
Canso Credit Income Fund Announces Special Distributions This Year

Updated Category News Views 171

Canso Credit Income Fund's Special Distributions Explained Lysander Funds Limited is excited to share important updates regarding the Canso Credit Income Fund (TSX: PBY). This announcement pertains to the special distributions being issued for various classes of units within the Fund for the tax year ending 2024. Understanding these distributions is vital for both...

Continue Reading
Blue Cross and Blue Shield of Texas Expands Community Support with Grants

Updated Category News Views 305

Blue Cross and Blue Shield of Texas Awards Community Grants Blue Cross and Blue Shield of Texas (BCBSTX) has announced an impressive investment of $2 million in community-based grants. This funding will go to 84 organizations across the state, all focused on enhancing accessibility to health services and tackling social determinants that significantly impact the...

Continue Reading
Dr. Soroush Baghdadi Enhances Pediatric Care at LuskinOIC

Updated Category News Views 338

Welcoming Dr. Soroush Baghdadi to Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children takes great pride in announcing the addition of Dr. Soroush Baghdadi to its distinguished team of pediatric orthopaedic specialists. With an impressive background enriched by global experience and a passion for pediatric care, Dr. Baghdadi brings a promising vision...

Continue Reading
Fractyl Health to Share Q3 Results and Business Insights Soon

Updated Category News Views 115

Fractyl Health to Discuss Upcoming Financial Insights In Burlington, Massachusetts, Fractyl Health, Inc. (Nasdaq: GUTS) is preparing to unveil its financial results for the third quarter of 2025 along with business updates. This event is scheduled for a Wednesday at 4:30 PM ET, where key insights into the company’s progress will be shared. Accessing the Live Event...

Continue Reading